Search in:

Drug Design, Development and Therapy Volume 10, 2016 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Gender differences in the adverse events’ profile registered in seven observational studies of a wide gender-medicine (MetaGeM) project: the MetaGeM safety analysis

Delia Colombo1 Patient Access, Novartis Farma S.p.A., Origgio, Varese

Emanuela Zagni1 Patient Access, Novartis Farma S.p.A., Origgio, VareseCorrespondence[email protected]

Mihaela Nica1 Patient Access, Novartis Farma S.p.A., Origgio, Varese

Sara Rizzoli2 MediNeos Observational Research, Modena, Italy

Alessandra Ori2 MediNeos Observational Research, Modena, Italy

Gilberto Bellia1 Patient Access, Novartis Farma S.p.A., Origgio, Varese

Pages 2917-2927 | Published online: 13 Sep 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (16)

Loreto Carmona, Elena Aurrecoechea & María Jesús García de Yébenes. (2023) Tailoring Rheumatoid Arthritis Treatment through a Sex and Gender Lens. Journal of Clinical Medicine 13:1, pages 55.
Crossref

Mythili Menon Pathiyil, Anuraag Jena, Arvind Kumar Venkataramana Raju, Tina Aswani Omprakash, Vishal Sharma & Shaji Sebastian. (2023) Representation and reporting of diverse groups in randomised controlled trials of pharmacological agents in inflammatory bowel disease: a systematic review. The Lancet Gastroenterology & Hepatology 8:12, pages 1143-1151.
Crossref

Christabel Khaemba, Abbie Barry, Wyckliff P. Omondi, Elvis Kirui, Margaret Oluka, Gurumurthy Parthasarathi, Sammy M. Njenga, Anastacia Guantai & Eleni Aklillu. (2023) Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study. Drug Safety 46:10, pages 961-974.
Crossref

Manuel Ibarra, Marianela Lorier & Iñaki F. Trocóniz. 2022. The ADME Encyclopedia. The ADME Encyclopedia 927 933 .

Han-Heui Park, Ju Hwan Kim, Dongwon Yoon, Hyesung Lee & Ju-Young Shin. (2021) Gender differences in the adverse events associated with cardiovascular drugs in a spontaneous reporting system in South Korea. International Journal of Clinical Pharmacy 43:4, pages 1036-1044.
Crossref

Christabel Khaemba, Abbie Barry, Wyckliff P. Omondi, Kefa Bota, Sultani Matendechero, Cecilia Wandera, Fred Siyoi, Elvis Kirui, Margaret Oluka, Pamela Nambwa, Parthasarathi Gurumurthy, Sammy M. Njenga, Anastacia Guantai & Eleni Aklillu. (2021) Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study. Pharmaceuticals 14:3, pages 264.
Crossref

Noriyuki Naya, Chika Sakai, Daiki Okutsu, Ryo Kiguchi, Masakazu Fujiwara, Toshinaga Tsuji & Akira Iwanami. (2020) Efficacy and safety of guanfacine extended‐release in Japanese adults with attention‐deficit/hyperactivity disorder: Exploratory post hoc subgroup analyses of a randomized, double‐blind, placebo‐controlled study. Neuropsychopharmacology Reports 41:1, pages 26-39.
Crossref

Manuel Ibarra, Marianela Lorier & Iñaki F. Trocóniz. 2021. The ADME Encyclopedia. The ADME Encyclopedia 1 7 .

Chung-Wang Lee, Yu Tung Lo, Sharmila Devi, Yookyung Seo, Angela Simon, Kelsey Zborovancik, Mona Y Alsheikh, Nayan Lamba, Timothy R Smith, Rania A Mekary & Linda S Aglio. (2020) Gender Differences in Preoperative Opioid Use in Spine Surgery Patients: A Systematic Review and Meta-analysis. Pain Medicine 21:12, pages 3292-3300.
Crossref

Sabra L. Klein & Rosemary Morgan. (2020) The impact of sex and gender on immunotherapy outcomes. Biology of Sex Differences 11:1.
Crossref

Mitchell R. K. L. Lie, Emma Paulides & C. Janneke van der Woude. (2020) Patient sex does not affect endoscopic outcomes of biologicals in inflammatory bowel disease but is associated with adverse events. International Journal of Colorectal Disease 35:8, pages 1489-1500.
Crossref

Mary V. Seeman. (2020) Men and women respond differently to antipsychotic drugs. Neuropharmacology 163, pages 107631.
Crossref

Danielle S Macêdo, Lia Lira Olivier Sanders, Raimunda das Candeias, Cyntia de Freitas Montenegro, David Freitas de Lucena, Adriano José Maia Chaves Filho, Mary V Seeman & Aline Santos Monte. (2020) G Protein-Coupled Estrogen Receptor 1 (GPER) as a Novel Target for Schizophrenia Drug Treatment. Schizophrenia Bulletin Open 1:1.
Crossref

Nadia Harbeck, Jessie Wang, Gordon Philipp Otto, Sreekanth Gattu & Andriy Krendyukov. (2019) Safety analysis of proposed pegfilgrastim biosimilar in Phase I and Phase III studies. Future Oncology 15:12, pages 1313-1322.
Crossref

Basil N. Okeahialam. (2017) Multidrug intolerance in the treatment of hypertension: result from an audit of a specialized hypertension service. Therapeutic Advances in Drug Safety 8:8, pages 253-258.
Crossref

Noa A Brzezinski-Sinai & Mary V Seeman. (2017) Women and schizophrenia: planning for the future. Future Neurology 12:2, pages 89-99.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Gender differences in the adverse events’ profile registered in seven observational studies of a wide gender-medicine (MetaGeM) project: the MetaGeM safety analysis

Articles from other publishers (16)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Gender differences in the adverse events’ profile registered in seven observational studies of a wide gender-medicine (MetaGeM) project: the MetaGeM safety analysis

Citations (16)

Articles from other publishers (16)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date